A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
Times cited: 137
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Journal of Clinical Oncology.
Times cited: 178